Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients

American Journal of Hypertension

Volumn 15, Issue 6, 2002, Pages 499-506

  Komai, Norio ^a   Ohishi, Mitsuru ^a   Morishita, Ryuichi ^a   Moriguchi, Atsushi ^a   Kaibe, Masaharu ^a   Matsumoto, Keiko ^a   Rakugi, Hiromi ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Arterial stiffness; Endothelial dysfunction; Essential hypertension; Growth factor; Hepatocyte; Reactive hyperemia

Indexed keywords

ATENOLOL; CILAZAPRIL; SCATTER FACTOR; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; FOREARM; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; STRAIN GAUGE TRANSDUCER; TREATMENT OUTCOME; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; DRUG EFFECT; EVALUATION; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION;

ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; ATENOLOL; BLOOD PRESSURE; CILAZAPRIL; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEPATOCYTE GROWTH FACTOR; HUMAN; HYPEREMIA; HYPERTENSION; MALE; MIDDLE AGE; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; VASODILATION; HUMANS; MIDDLE AGED;

EID: 0036015037     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)02274-4     Document Type: Article

References (27)

1. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
2. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women
3. Converting enzyme inhibitor improves forearm RH in essential hypertension
4. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: A multicenter study
5. Pulse pressure in essential hypertension: Clinical and therapeutical implications
6. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients
7. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension
8. Partial purification and characterization of hepatocyte growth from serum of hepatectomized rats
9. Molecular cloning and expression of human hepatocyte growth factor
10. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor
11. Assessment of arterial distensibility by automatic pulse wave velocity measurement: Validation and clinical application studies
12. Arterial stiffness and cardiovascular risk factors in a population-based study
13. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior study
14. Improvement in blood pressure, arterial stiffness and wave reflection with a very low dose perindopril/indapamide combination in hypertensive patients: A comparison with atenolol
15. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
16. Close relation of endothelial function in the human coronary and peripheral circulations
17. Systemic endothelial dysfunction is related to extent and severity of coronary artery diseases
18. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension
19. Effects of angiotensin-converting enzyme inhibition versus β-adrenergic blockade on aortic stiffness in essential hypertension
20. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell mortality and growth
21. Role of angiotensin II in the regulation of novel vascular modulator, hepatocyte growth factor, in experimental hypertensive rats
22. Negative regulation of local hepatocyte growth factor (HGF) expression by angiotensin II and transforming growth factor-beta in blood vessels: Potential role of HGF in cardiovascular disease
23. Hyperhomocysteinemia is a risk factor for aterial endothelial dysfunction in humans
24. von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: Relationship to degree of liver failure and nitric oxide levels
25. von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?
26. von Willebrand factor and the endothelium in vascular diseases